Ankylosing Spondylitis, Rheumatologic PerspectiveMedical Author:
William C. Shiel Jr., MD, FACP, FACR
William C. Shiel Jr., MD, FACP, FACRDr. Shiel received a Bachelor of Science degree with honors from the University of Notre Dame. There he was involved in research in radiation biology and received the Huisking Scholarship. After graduating from St. Louis University School of Medicine, he completed his Internal Medicine residency and Rheumatology fellowship at the University of California, Irvine. He is board-certified in Internal Medicine and Rheumatology. Medical Editor:
Melissa Conrad Stöppler, MD, Chief Medical Editor
Melissa Conrad Stöppler, MD, Chief Medical EditorMelissa Conrad Stöppler, MD, is a U.S. board-certified Anatomic Pathologist with subspecialty training in the fields of Experimental and Molecular Pathology. Dr. Stöppler's educational background includes a BA with Highest Distinction from the University of Virginia and an MD from the University of North Carolina. She completed residency training in Anatomic Pathology at Georgetown University followed by subspecialty fellowship training in molecular diagnostics and experimental pathology.
AS Rheumatologic OverviewAnkylosing spondylitis (AS) is a type of arthritis that causes inflammation of the spine and the sacroiliac joints (joints between the lowest end of the spine, the sacrum, and the pelvis). The affected joints and ligaments become swollen and painful, leading to stiffness in the back and neck. As the disease progresses, the vertebrae can fuse together, making the spine rigid and inflexible, eventually making the joints immovable. Ankylosing spondylitis can also affect other joints away from the spine as well as cause inflammation of tendons and ligaments. Ankylosing spondylitis affects approximately 0.1-0.2% of the population. It most commonly affects young males, but females can be affected. Females often experience a somewhat less severe form of the disease. The usual age of onset is from the late teens to 40 years of age. Approximately 10-20% of all people with ankylosing spondylitis have onset of symptoms when younger than 16 years, and this form of AS is referred to as juvenile-onset ankylosing spondylitis. |
Arthritis
Get the latest treatment options
From WebMD
Arthritis Resources
Featured Centers
- Ask the Nutritionist: Weight Loss Tips
- Which Drugstore Tooth Whiteners Work Best?
- Gout: Symptoms, Causes, and Treatments
Health Solutions From Our Sponsors
Ankylosing Spondylitis, Rheumatologic Perspective
Juvenile Rheumatoid Arthritis »
Juvenile Rheumatoid Arthritis Overview
Rheumatoid arthritis, often called RA, is a chronic (long-standing) disease that damages and eventually destroys the joints of the body. The damage is caused by inflammation, a normal response of the body’s immune system. Arthritis means “joint inflammation.”
- The inflammation in the joints causes pain, stiffness, and swelling as well as many other symptoms.
- The inflammation often affects other organs and systems of the body as well.
- If the inflammation is not slowed down or stopped, it eventually destroys the affected joints and other tissues.
Read What Your Physician is Reading on Medscape
Ankylosing Spondylitis and Undifferentiated Spondyloarthropathy »
The spondyloarthropathies (SpAs) are a family of related disorders that includes ankylosing spondylitis (AS), reactive arthritis (ReA; also known as Reiter syndrome [RS]), psoriatic arthritis (PsA), spondyloarthropathy associated with inflammatory bowel disease (IBD), undifferentiated spondyloarthropathy (USpA), and, possibly, Whipple disease and Behçet disease.
Featured Topics
Medical Dictionary
Pill Identifier on RxList
- quick,
easy,
pill identification
Find a Local Pharmacy
- including
24 hour
pharmacies

